Los Angeles A U.S. appeals court on Tuesday ruled against Swiss drugmaker Novartis AG in a patent infringement dispute concerning its blockbuster multiple sclerosis drug Gilenya. The U.S. Court of Appeals for the Federal Circuit, which hears patent appeals, reversed its own earlier ruling in the case. A divided panel found Novartis’ patent was invalid…
Read More
Fakty Miami Top News:
- Headed to a Disney Theme Park? You May Not Like This
- The Dollar Has Been Inflating Against Bitcoin Since 2011
- ‘Downwell’ creator debuts new game ‘Poinpy’ on Netflix
- Stressful state of digital; Only 26% trust news…
- Ex-Editor: Conservatives purged from USATODAY by ‘Diversity committees’…
- 32nd annual Hong Kong Book Fair returns on 20 July
- US Open Golf 2022: Collin Morikawa, Joel Dahmen Share Lead Entering Round 3
- Victoria scraps masks in airports, vaccine mandates
Saturday, June 25